Navigation Links
Study Shows Brain Fitness can Save Medicare Billions
Date:8/4/2009

SAN FRANCISCO, Aug. 4 /PRNewswire/ -- Just ten hours of the right brain fitness exercises can have a significant and long lasting impact on healthcare costs and outcomes, according to a study recently published in BMC Health Services Research, a leading peer-reviewed health services journal.

Researchers found that participants who did just ten hours of special computerized brain exercises had better health outcomes, lowering projected Medicare costs by hundreds of dollars per year. As the number of Medicare enrollees grows from 44 million to 61 million over the next ten years, this represents more than $100 billion in potential savings.

The report is part of a multi-site trial funded by the National Institutes of Health and known as the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) study. There were 2,802 healthy adults, aged 65 and older, enrolled in the study. The participants were divided into three intervention groups and a no contact control group. The intervention groups received classroom training in reasoning or memory strategies or took part in computerized brain fitness exercises. Each intervention was based on a total of ten hours of training over one initial six-week period. Participants have been followed for more than five years.

The ACTIVE study team previously reported that participants who performed the computerized brain exercises had significantly improved health outcomes, as measured by a widely used instrument assessing health-related quality of life, known as the SF-36. In this report, researchers used a model recently developed by the federal Agency for Healthcare Research and Quality (AHRQ) to predict healthcare costs, based on massive correlation of actual healthcare costs to SF-36 scores.

The researchers found that a year following training with the brain fitness software, now owned and marketed by Posit Science Corporation, participants predicted healthcare costs that were $244 less per patient than in the control group, after adjustment for differences in the groups (or $223 on an unadjusted basis.) The differences between the groups were statistically significant and only the group using the Posit Science(R) software showed significant savings.

"Our results have important health policy relevance," said Frederic Wolinsky, PhD, of the University of Iowa who was lead author on the article. "The reduced costs were equal to about three-to-four percent of annual healthcare costs for Medicare patients at the time of the study."

Even five years later, with no further training, trend data indicated that those patients had lower predicted healthcare costs by about $143 less per year (or $128 on an unadjusted basis.)

"This data indicates that we can have better health outcomes at significantly lower costs," said Henry Mahncke, PhD, vice president of Research at Posit Science. "It also suggests that ongoing brain fitness training benefits not just the individual, but the entire healthcare system."

Posit Science

Posit Science is the leader in clinically proven brain fitness programs. The company works with over 50 scientists from prestigious universities to design and test its interactive computer-based programs. More than 30 articles in leading science and medical journals show that in randomized controlled trials the company's patented technologies significantly increase processing speed, improve memory and attention and enhance quality of life. Posit Science has received grants from the National Institutes of Health and numerous awards and accolades. The company's products, scientists and science are currently featured in the PBS documentary "The Brain Fitness Program." For more information, visit www.PositScience.com or call 1-866-599-6463.

Posit Science is a registered trademark of Posit Science Corporation. Other company and product names may be trademarks of their respective owners.


'/>"/>
SOURCE Posit Science
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
2. OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer
3. Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window
4. Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
5. Cyberonics Provides Update on Depression Post-Approval Study
6. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
7. R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
8. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
9. Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
10. Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
11. Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):